Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087594637> ?p ?o ?g. }
- W3087594637 endingPage "253" @default.
- W3087594637 startingPage "246" @default.
- W3087594637 abstract "•Axial myopia has increased vitreous echodensity and decreased contrast sensitivity. •PVD further increases vitreous density and degrades contrast sensitivity in myopia. •Limited vitrectomy normalizes contrast sensitivity function in myopic vitreopathy. Purpose Myopic vitreopathy features precocious fibrous vitreous liquefaction and early posterior vitreous detachment (PVD). It is unclear whether visual function is affected by myopic vitreopathy and PVD. This study assessed the relationships among axial length, structural vitreous density, PVD, and visual function. Design Retrospective case-control study. Methods Ultrasonography measurements were made of axial length, logMAR VA, contrast sensitivity function (CSF [Freiburg acuity contrast test]), and quantitative B-scan ultrasonography. Results Seventy-nine subjects (45 men and 34 women; mean age: 49 ± 14 years) were analyzed. Axial lengths ranged from 22 to 29.2 mm (mean: 24.9 ± 1.8 mm; myopic eyes: 26.35 ± 1.35 mm; and nonmyopic eyes: 23.45 ± 0.75 mm; P < .001). With increasing axial length there was greater vitreous echodensity (R: 0.573; P < .01) and degradation in CSF (R: 0.611; P < .01). Subgroup analyses found that myopic eyes (>− 3 diopters) had 37% more vitreous echodensity than nonmyopic eyes (762 ± 198 arbitrary units [AU] vs. 557 ± 171 AU, respectively; P < .001) and that CSF was 53% worse in myopic eyes (3.30 ± 1.24 Weber index [%W]) than in nonmyopic eyes (2.16 ± .59 %W; P < .001). Myopic eyes with PVD had 33% greater vitreous echodensity (815 ± 217 AU; P < .001) and 62% degradation in CSF (3.63 ± 2.99 %W) compared to nonmyopic eyes with PVD (613 ± 159 AU; 2.24 ± 0.69 %W; P < .001, each). Limited vitrectomy was performed in 11 of 40 cases (27.5%), normalizing vitreous echodensity and CSF in each case. Conclusions Axial myopia is associated with increased fibrous vitreous liquefaction and echodensity, as well as profound degradation of CSF. PVD in myopic eyes is associated with even more structural and functional abnormalities, normalized by limited vitrectomy. These findings may explain some common complaints of myopic patients with respect to vision and quality of life. Myopic vitreopathy features precocious fibrous vitreous liquefaction and early posterior vitreous detachment (PVD). It is unclear whether visual function is affected by myopic vitreopathy and PVD. This study assessed the relationships among axial length, structural vitreous density, PVD, and visual function. Retrospective case-control study. Ultrasonography measurements were made of axial length, logMAR VA, contrast sensitivity function (CSF [Freiburg acuity contrast test]), and quantitative B-scan ultrasonography. Seventy-nine subjects (45 men and 34 women; mean age: 49 ± 14 years) were analyzed. Axial lengths ranged from 22 to 29.2 mm (mean: 24.9 ± 1.8 mm; myopic eyes: 26.35 ± 1.35 mm; and nonmyopic eyes: 23.45 ± 0.75 mm; P < .001). With increasing axial length there was greater vitreous echodensity (R: 0.573; P < .01) and degradation in CSF (R: 0.611; P < .01). Subgroup analyses found that myopic eyes (>− 3 diopters) had 37% more vitreous echodensity than nonmyopic eyes (762 ± 198 arbitrary units [AU] vs. 557 ± 171 AU, respectively; P < .001) and that CSF was 53% worse in myopic eyes (3.30 ± 1.24 Weber index [%W]) than in nonmyopic eyes (2.16 ± .59 %W; P < .001). Myopic eyes with PVD had 33% greater vitreous echodensity (815 ± 217 AU; P < .001) and 62% degradation in CSF (3.63 ± 2.99 %W) compared to nonmyopic eyes with PVD (613 ± 159 AU; 2.24 ± 0.69 %W; P < .001, each). Limited vitrectomy was performed in 11 of 40 cases (27.5%), normalizing vitreous echodensity and CSF in each case. Axial myopia is associated with increased fibrous vitreous liquefaction and echodensity, as well as profound degradation of CSF. PVD in myopic eyes is associated with even more structural and functional abnormalities, normalized by limited vitrectomy. These findings may explain some common complaints of myopic patients with respect to vision and quality of life." @default.
- W3087594637 created "2020-09-25" @default.
- W3087594637 creator A5013092199 @default.
- W3087594637 creator A5014869361 @default.
- W3087594637 creator A5034544046 @default.
- W3087594637 creator A5063488128 @default.
- W3087594637 creator A5065452265 @default.
- W3087594637 creator A5076167293 @default.
- W3087594637 date "2021-04-01" @default.
- W3087594637 modified "2023-10-16" @default.
- W3087594637 title "Vitreous Structure and Visual Function in Myopic Vitreopathy Causing Vision-Degrading Myodesopsia" @default.
- W3087594637 cites W1976310307 @default.
- W3087594637 cites W1982602058 @default.
- W3087594637 cites W2004452689 @default.
- W3087594637 cites W2007218705 @default.
- W3087594637 cites W2013097262 @default.
- W3087594637 cites W2048790927 @default.
- W3087594637 cites W2050812224 @default.
- W3087594637 cites W2051809095 @default.
- W3087594637 cites W2054488325 @default.
- W3087594637 cites W2064163865 @default.
- W3087594637 cites W2064766975 @default.
- W3087594637 cites W2065240391 @default.
- W3087594637 cites W2065651845 @default.
- W3087594637 cites W2067095492 @default.
- W3087594637 cites W2077842194 @default.
- W3087594637 cites W2078470222 @default.
- W3087594637 cites W2085343042 @default.
- W3087594637 cites W2090981020 @default.
- W3087594637 cites W2113491252 @default.
- W3087594637 cites W2196444154 @default.
- W3087594637 cites W2263495255 @default.
- W3087594637 cites W2280059135 @default.
- W3087594637 cites W2317993629 @default.
- W3087594637 cites W2343509028 @default.
- W3087594637 cites W2520957924 @default.
- W3087594637 cites W2558931807 @default.
- W3087594637 cites W2565182282 @default.
- W3087594637 cites W2602323930 @default.
- W3087594637 cites W2791157006 @default.
- W3087594637 cites W2802532377 @default.
- W3087594637 cites W2888759171 @default.
- W3087594637 cites W2920381415 @default.
- W3087594637 cites W2951897223 @default.
- W3087594637 cites W2954311256 @default.
- W3087594637 cites W2961218446 @default.
- W3087594637 cites W2963237512 @default.
- W3087594637 cites W2984551964 @default.
- W3087594637 cites W3009581701 @default.
- W3087594637 doi "https://doi.org/10.1016/j.ajo.2020.09.017" @default.
- W3087594637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32950508" @default.
- W3087594637 hasPublicationYear "2021" @default.
- W3087594637 type Work @default.
- W3087594637 sameAs 3087594637 @default.
- W3087594637 citedByCount "17" @default.
- W3087594637 countsByYear W30875946372021 @default.
- W3087594637 countsByYear W30875946372022 @default.
- W3087594637 countsByYear W30875946372023 @default.
- W3087594637 crossrefType "journal-article" @default.
- W3087594637 hasAuthorship W3087594637A5013092199 @default.
- W3087594637 hasAuthorship W3087594637A5014869361 @default.
- W3087594637 hasAuthorship W3087594637A5034544046 @default.
- W3087594637 hasAuthorship W3087594637A5063488128 @default.
- W3087594637 hasAuthorship W3087594637A5065452265 @default.
- W3087594637 hasAuthorship W3087594637A5076167293 @default.
- W3087594637 hasConcept C118487528 @default.
- W3087594637 hasConcept C120665830 @default.
- W3087594637 hasConcept C121332964 @default.
- W3087594637 hasConcept C259533 @default.
- W3087594637 hasConcept C2776502983 @default.
- W3087594637 hasConcept C2778257484 @default.
- W3087594637 hasConcept C2779676219 @default.
- W3087594637 hasConcept C2780428090 @default.
- W3087594637 hasConcept C2780827179 @default.
- W3087594637 hasConcept C2781135284 @default.
- W3087594637 hasConcept C2781242345 @default.
- W3087594637 hasConcept C71924100 @default.
- W3087594637 hasConceptScore W3087594637C118487528 @default.
- W3087594637 hasConceptScore W3087594637C120665830 @default.
- W3087594637 hasConceptScore W3087594637C121332964 @default.
- W3087594637 hasConceptScore W3087594637C259533 @default.
- W3087594637 hasConceptScore W3087594637C2776502983 @default.
- W3087594637 hasConceptScore W3087594637C2778257484 @default.
- W3087594637 hasConceptScore W3087594637C2779676219 @default.
- W3087594637 hasConceptScore W3087594637C2780428090 @default.
- W3087594637 hasConceptScore W3087594637C2780827179 @default.
- W3087594637 hasConceptScore W3087594637C2781135284 @default.
- W3087594637 hasConceptScore W3087594637C2781242345 @default.
- W3087594637 hasConceptScore W3087594637C71924100 @default.
- W3087594637 hasLocation W30875946371 @default.
- W3087594637 hasOpenAccess W3087594637 @default.
- W3087594637 hasPrimaryLocation W30875946371 @default.
- W3087594637 hasRelatedWork W1538734 @default.
- W3087594637 hasRelatedWork W1982024861 @default.
- W3087594637 hasRelatedWork W1982712292 @default.
- W3087594637 hasRelatedWork W2026297555 @default.
- W3087594637 hasRelatedWork W2081790449 @default.
- W3087594637 hasRelatedWork W2087309527 @default.